Literature DB >> 19362044

Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.

Sabrina Daniela da Silva1, Isabela Werneck Cunha, Inês Nobuko Nishimoto, Fernando Augusto Soares, Dirce Maria Carraro, Luiz Paulo Kowalski, Edgard Graner.   

Abstract

Overexpression of fatty acid synthase (FASN) and ErbB2 has been described in oral squamous cell carcinomas (OSCC). FASN is the key lipogenic enzyme responsible for the endogenous synthesis of fatty acids and its expression can be regulated by ErbB2. The deubiquitinating enzyme (DUB) ubiquitin-specific protease 2a (USP2a) plays a critical role in prostate cancer cell survival by stabilizing the FASN protein. This study investigates whether the gene expression and the immunohistochemical status of FASN, ErbB2, and USP2a correlate with the clinicopathological characteristics of OSCC cases. A strong positive correlation among ErbB2, FASN, and USP2a expression (p=0.001) was observed by qRT-PCR in laser capture microdissected OSCC samples. Perineural infiltration was associated with ErbB2 mRNA expression (p=0.046). The presence of metastatic cervical lymph nodes was associated with FASN (p=0.002), ErbB2 (p=0.001), and USP2a (p=0.006) mRNA levels. ErbB2 staining at the cell membranes was stronger in well-differentiated lesions while a cytoplasmic positivity was found in poorly differentiated tumors. Most of the OSCC (97.06%) that showed a high positivity for FASN were also labeled for ErbB2 at the cell membranes (p=0.001). FASN and ErbB2 positivity was associated with tumor thickness and lymphatic embolization (p=0.006 and p=0.035, p=0.006 and p=0.024 respectively). The membrane expression of ErbB2 as well as FASN and Ki-67 staining were significantly associated with a high risk of recurrence by predicting both disease free survival (log-rank test, p=0.0056, p=0.0011, and p=0.0004, respectively) and overall survival (log-rank test, p=0.0005, p=0.0062, and p=0.0001, respectively). Taken together, the results presented here suggest a molecular connection among FASN, ErbB2, and USP2a in OSCC since their mRNA and protein levels were associated with tumor progression and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362044     DOI: 10.1016/j.oraloncology.2009.02.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.

Authors:  Yan Shi; Larry R Solomon; Ana Pereda-Lopez; Vincent L Giranda; Yan Luo; Eric F Johnson; Alexander R Shoemaker; Joel Leverson; Xuesong Liu
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

2.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

3.  Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.

Authors:  Sabrina Daniela Silva; Moulay A Alaoui-Jamali; Michael Hier; Fernando Augusto Soares; Edgard Graner; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2013-12-15       Impact factor: 5.150

4.  Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors.

Authors:  Kosuke Miyai; Keiichi Iwaya; Tomohiko Asano; Seiichi Tamai; Osamu Matsubara; Hitoshi Tsuda
Journal:  Virchows Arch       Date:  2013-12-14       Impact factor: 4.064

5.  Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.

Authors:  Débora C Bastos; Jenny Paupert; Catherine Maillard; Fabiana Seguin; Marco A Carvalho; Michelle Agostini; Ricardo D Coletta; Agnès Noël; Edgard Graner
Journal:  Lab Invest       Date:  2016-12-05       Impact factor: 5.662

6.  Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes.

Authors:  Qi-qiang Long; Yong-xiang Yi; Jie Qiu; Chuan-jun Xu; Pei-lin Huang
Journal:  Tumour Biol       Date:  2014-01-17

7.  Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation.

Authors:  David J Wisniewski; Tao Ma; Abraham Schneider
Journal:  Exp Cell Res       Date:  2018-06-30       Impact factor: 3.905

8.  Immunohistochemical Expression of Fatty Acid Synthase (FASN) is Correlated to Tumor Aggressiveness and Cellular Differentiation in Salivary Gland Carcinomas.

Authors:  Camila Matsunaga de Angelis; Reydson Alcides de Lima-Souza; João Figueira Scarini; Erika Said Abu Egal; Gleyson Kleber do Amaral-Silva; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Carlos Takahiro Chone; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano
Journal:  Head Neck Pathol       Date:  2021-04-11

9.  The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.

Authors:  F Seguin; M A Carvalho; D C Bastos; M Agostini; K G Zecchin; M P Alvarez-Flores; A M Chudzinski-Tavassi; R D Coletta; E Graner
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

10.  Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization.

Authors:  Minyoung Noh; Haiying Zhang; Hyejeong Kim; Songyi Park; Young-Myeong Kim; Young-Guen Kwon
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.